نتایج جستجو برای: rankl

تعداد نتایج: 3831  

2016
Hitomi Kurinami Munehisa Shimamura Hironori Nakagami Hideo Shimizu Hiroshi Koriyama Tomohiro Kawano Kouji Wakayama Hideki Mochizuki Hiromi Rakugi Ryuichi Morishita

The enhanced receptor activator of nuclear factor-κB (NFκB) ligand (RANKL) and its receptor (RANK) signal have been reported to attenuate ischemic brain injury through inhibition of Toll-like receptor (TLR) 4-mediated inflammation. However, augmentation of the RANKL/RANK signal also accelerates osteoporosis, which is a potential problem in clinical use of RANKL. Therefore, we developed novel pe...

Journal: :JCI insight 2016
Anna Cline-Smith Jesse Gibbs Elena Shashkova Zachary S Buchwald Deborah V Novack Rajeev Aurora

A number of studies in model animal systems and in the clinic have established that RANKL promotes bone resorption. Paradoxically, we found that pulsing ovariectomized mice with low-dose RANKL suppressed bone resorption, decreased the levels of proinflammatory effector T cells and led to increased bone mass. This effect of RANKL is mediated through the induction of FoxP3+CD25+ regulatory CD8+ T...

Journal: :Journal of musculoskeletal & neuronal interactions 2004
L C Hofbauer C A Kühne V Viereck

The OPG/RANKL/RANK cytokine system is essential for osteoclast biology. Various studies suggest that human metabolic bone diseases are related to alterations of this system. Here we summarize OPG/RANKL/RANK abnormalities in different forms of osteoporoses and hyperparathyroidism. Skeletal estrogen agonists (including 17beta-estradiol, raloxifene, and genistein) induce osteoblastic OPG productio...

Journal: :Thrombosis and haemostasis 2012
Alessandra Quercioli François Mach Maria Bertolotto Sébastien Lenglet Nicolas Vuilleumier Katia Galan Sabrina Pagano Vincent Braunersreuther Graziano Pelli Vito Pistoia Giovanna Bianchi Giuseppe Cittadini Giorgio Luciano Viviani Aldo Pende Pascale Roux-Lombard Aurélien Thomas Christian Staub Osman Ratib Franco Dallegri Thomas Helmut Schindler Fabrizio Montecucco

The "blood vulnerability", resulting from the complex balance between serum molecules and inflammatory cell atherosclerotic activities, is a major determinant in the evaluation of the "global patient cardiovascular vulnerability". In the present study, we focused on the role of the soluble receptor activator of nuclear factor kappa-B (NF-κB) ligand (RANKL, a potential marker of coronary calcifi...

Journal: :The Journal of bone and joint surgery. British volume 2003
J Mandelin T F Li M Liljeström M E Kroon R Hanemaaijer S Santavirta Y T Konttinen

In the differentiation of osteoclasts the differentiation factor (RANKL) interacts with the receptor activator of NF-kappaB (RANK) in a direct cell-to-cell contact between osteoblast and (pre)osteoclast. This is inhibited by soluble osteoprotegerin (OPG). The mRNA levels of both RANKL (p < 0.01) and RANK (p < 0.05) were high in peri-implant tissue and RANKL+ and RANK+ cells were found in such t...

2014
Aneta Schieferdecker Mareike Voigt Kristoffer Riecken Friederike Braig Thorsten Schinke Sonja Loges Carsten Bokemeyer Boris Fehse Mascha Binder

Bone homeostasis critically relies on the RANKL-RANK-OPG axis which can be targeted by the fully human monoclonal antibody denosumab in conditions with increased bone resporption such as bone metastases. The binding site and therefore the molecular mechanism by which this antibody inhibits RANKL has not been characterized so far. Here, we used random peptide phage display library screenings to ...

2011
K. Sfiridaki C. A. Pappa G. Tsirakis P. Kanellou M. Kaparou M. Stratinaki G. Sakellaris G. Kontakis M. G. Alexandrakis

An essential cytokine system for the osteoclast biology in multiple myeloma (MM) consists of the receptor of activator of NF-κB ligand (RANKL), its receptor (RANK), and the soluble decoy receptor, osteoprotegerin (OPG). Myeloma cells cause imbalance in OPG/RANKL interactions. We measured serum levels of OPG, soluble (s) RANKL, sRANKL/OPG ratio, markers of disease activity [LDH, CRP, interleukin...

Journal: :Endocrinology 2001
K Itoh N Udagawa T Katagiri S Iemura N Ueno H Yasuda K Higashio J M Quinn M T Gillespie T J Martin T Suda N Takahashi

Bone is a major storage site for TGFbeta superfamily members, including TGFbeta and bone morphogenetic proteins. It is believed that these cytokines are released from bone during bone resorption. Recent studies have shown that both RANKL and macrophage colony-stimulating factor are two essential factors produced by osteoblasts for inducing osteoclast differentiation. In the present study we exa...

2015
Jingxuan Wang Kangping Lu Ying Song Shu Zhao Wenjie Ma Qijia Xuan Dabei Tang Hong Zhao Lei Liu Qingyuan Zhang Pierre J Marie

BACKGROUND Breast cancer patients treated with aromatase inhibitors (AIs) may experience musculoskeletal adverse events (MS-AEs). Several studies have confirmed that the RANKL/RANK/OPG signaling pathway plays a dominant role in bone health. Therefore, this study aimed to analyze the relationship between the serum levels of RANKL, OPG and their SNPs (single nucleotide polymorphisms) with AI-rela...

Journal: :The Journal of biological chemistry 2012
Melda Onal Jinhu Xiong Xinrong Chen Jeff D Thostenson Maria Almeida Stavros C Manolagas Charles A O'Brien

Production of the cytokine receptor activator of NFκB ligand (RANKL) by lymphocytes has been proposed as a mechanism by which sex steroid deficiency causes bone loss. However, there have been no studies that functionally link RANKL expression in lymphocytes with bone loss in this condition. Herein, we examined whether RANKL expression in either B or T lymphocytes contributes to ovariectomy-indu...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید